Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor

Journal of Molecular Biology

Volumn 316, Issue 3, 2002, Pages 769-787

  Pan, Borlan ^a   Li, Bing ^a   Russell, Stephen J ^a   Tom, Jeffrey Y K ^a   Cochran, Andrea G ^a   Fairbrother, Wayne J ^a  

^a GENENTECH INC   (United States)

Author keywords

Angiogenesis; NMR; Peptide antagonist; Protein structure; Vascular endothelial growth factor

Indexed keywords

CARBON 13; GLYCYLGLYCYLASPARAGINYLGLUTAMYLCYSTEINYLASPARTYLALANYLISOLEUCYLARGINYLMETHI ONYLTRYPTOPHYLGLUTAMYLTRYPTOPHYLGLUTAMYLCYSTEINYLPHENYLALANYLGLUTAMYLARGINYLLEUC INE; MONOMER; NITROGEN 15; PROTEIN; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; V 107; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ACCURACY; ANGIOGENESIS; ARTICLE; CALCULATION; CRYSTAL STRUCTURE; DRUG BINDING SITE; DRUG POTENCY; DRUG PROTEIN BINDING; ENDOTHELIUM CELL; HYDROPHOBICITY; NUCLEAR MAGNETIC RESONANCE; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE;

EID: 0036300518     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2001.5370     Document Type: Article

References (75)

1. Role of vascular endothelial growth factor in regulation of physiological angiogenesis
2. Vascular endothelial growth factor: Crystal structure and functional mapping of the kinase domain receptor binding site
3. The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 Å resolution: Multiple copy flexibility and receptor binding
4. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms
5. Disulfide structure of the heparin binding domain in vascular endothelial growth factor: Characterization of posttranslational modifications in VEGF
6. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
7. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
8. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis
9. Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice
10. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2)
11. Vascular endothelial growth factor. The trigger for neovascularization in the eye
12. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders
13. VEGF and the Fab fragment of a humanized neutralizing antibody: Crystal structure of the complex at 2.4 Å resolution and mutational analysis of the interface
14. Selection and analysis of an optimized anti-VEGF antibody: Crystal structure of an affinity-matured Fab in complex with antigen
15. Crystal structure at 1.7 Å resolution of VEGF in complex with domain 2 of the Flt-1 receptor
16. Solution structure of the VEGF-binding domain of Flt-1: Comparison of its free and bound states
17. De novo design and synthesis of somatostatin non-peptide peptidomimetics utilizing β-D-glucose as a novel scaffolding
18. Benzodiazepine peptidomimetics: Potent inhibitors of Ras farnesylation in animal cells
19. From peptide to non-peptide. 1. The elucidation of a bioactive conformation of the arginine-glycine-aspartic acid recognition sequence
20. From peptide to non-peptide. 2. The de novo design of potent, non-peptidal inhibitors of platelet aggregation based on a benzodiazepinedione scaffold
21. Growth hormone secretagogues: Characterization, efficacy, and minimal bioactive conformation
22. Design, synthesis and binding affinities of novel non-peptide mimics of somatostatin/sandostatin
23. 1H-1,4-benzodiazepine-2,5-dione nucleus
24. Potent α4β1 peptide antagonists as potential anti-inflammatory agents
25. Novel peptides selected to bind vascular endothelial growth factor target the receptor-binding site
26. Crystal structure of the complex between VEGF and a receptor-blocking peptide
27. 15N backbone assignment and secondary structure of the receptor-binding domain of vascular endothelial growth factor
28. 15N resonance assignment of the vascular endothelial growth factor receptor-binding domain in complex with a receptor-blocking peptide
29. AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR
30. A structural superfamily of growth factors containing a cystine knot motif
31. Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor
32. Receptor-selective variants of human vascular endothelial growth factor. Generation and characterization
33. Direct measurement of distances and angles in biomolecules by NMR in a dilute liquid crystalline medium
34. 13C couplings in the structure determination of magnetically oriented macromolecules in solution
35. Molecular mimics of insulin-like growth factor 1 (IGF-1) for inhibiting IGF-1: IGF-binding protein interactions
36. Structure-function analysis of a phage display-derived peptide that binds to insulin-like growth factor binding protein 1
37. Inhibiting HIV-1 entry: Discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket
38. Peptide exosite inhibitors of factor VIIa as anticoagulants
39. Functional mimicry of a protein hormone by a peptide agonist: The EPO receptor complex at 2.8 Å
40. Amino acid determinants of β-hairpin conformation in erythropoeitin receptor agonist peptides derived from a phage display library
41. A novel family of hairpin peptides that inhibit IgE activity by binding to the high-affinity IgE receptor
42. Crystallization of the receptor binding domain of vascular endothelial growth factor
43. Imitation of Escherichia coli aspartate receptor signaling in engineered dimers of the cytoplasmic domain
44. 15N chemical shift referencing in biomolecular NMR
45. TROSY in triple-resonance experiments: New perspectives for sequential NMR assignment of large proteins
46. 2O samples of proteins
47. 2O
48. 13C HMQC-NOESY experiment for extracting intermolecular NOE contacts in molecular complexes
49. 15N-labeled proteins
50. Methods for measurement of intermolecular NOEs by multinuclear NMR spectroscopy: Application to a bacteriophage N-peptide/boxB RNA complex
51. 2O saturation
52. Gradient-enhanced triple-resonance three-dimensional NMR experiments with improved sensitivity
53. 1H]-TROSY elements in triple resonance experiments
54. Transverse-relaxation-optimized (TROSY) gradient-enhanced triple-resonance NMR spectroscopy
55. Improved sensitivity of HSQC spectra of exchanging protons at short interscan delays using a new fast HSQC (FHSQC) detection scheme that avoids water saturation
56. 2O in protein NMR. Applications to sensitivity enhancement and NOE measurements
57. An adiabatic multiple spin-echo pulse sequence: Removal of systematic errors due to pulse imperfections and off-resonance effects
58. An improved sequence for broadband decoupling: WALTZ-16
59. Computer-optimized decoupling scheme for wideband applications and low-level operation
60. The program XEASY for computer-supported NMR speactral analysis of biological macromolecules
61. Tunable alignment of macromolecules by filamentous phage yields dipolar coupling interactions
62. Measurement of J and dipolar couplings from simplified two-dimensional NMR spectra
63. Scaling NOESY crosspeaks involving methyl protons
64. Pseudostructures for the 20 common amino acids for use in studies of protein conformation by measurements of intramolecular proton-proton distance constraints with nuclear magnetic resonance
65. Dipolar relaxation and nuclear Overhauser effects in nonrigid molecules: The effect of fluctuating internuclear distances
66. Calculation of the nuclear Overhauser effect and the determination of proton-proton distances in the presence of internal motions
67. Three-dimensional structure of proteins determined by molecular dynamics with interproton distance restraints: Application to crambin
68. Application of molecular dynamics with interproton distance restraints to three-dimensional protein structure determination. A model study of crambin
69. Protein backbone angle restraints from searching a database for chemical shift and sequence homology
70. β chemical shifts on protein structure determination by NMR
71. 1H NMR
72. Torsion-angle molecular dynamics as a new efficient tool for NMR structure calculation
73. Direct structure refinement against residual dipolar couplings in the presence of rhombicity of unknown magnitude
74. MOLMOL: A program for display and analysis of macromolecular structures